期刊文献+

p27蛋白在肺腺癌中的表达及临床意义

Expression and clinical importance of p27 in adenocarcinoma of lung
下载PDF
导出
摘要 目的探讨p27蛋白在肺腺癌的表达及临床意义。方法应用免疫组化技术检测44例肺腺癌患者的p27蛋白表达,分析p27蛋白表达与性别、年龄、肿瘤大小、临床分期、分化程度和淋巴结转移以及预后的关系。结果p27蛋白水平与肺腺癌的分化程度相关,与患者的年龄、性别、肿瘤大小、淋巴结转移、TMN分期无关。p27蛋白低表达者的平均生存期(18.6个月)明显低于p27蛋白高表达者(34.5个月)。结论p27蛋白表达可以作为评价肺腺癌恶性程度和预后的一个重要指标。 [ Objective] To discuss the expression and clinical importance of p27 in adenocarcinoma of lung. [ Method] The expression of p27 were detected by immunohistochemical technique for 44 patients with adenocarcinoma of lung who were confirmed by pathology. The correlation of p27 with sex, age, volume of tumor, clinical stage, lymphatic metastasis, and prognosis were analysised. [ Result ] p27 protein was closely positive correlation with adenocarcinoma of lung,and was no correlation with sex, age, volume of tumor, clinical stage and lymphatic metastasis. The mean survival duration of low p27 protein expression (34. 5 months) was below that of high p27 protein expression (18. 6 months). [ Conclusion ] p27 protein was a marker factor that evaluated the malignancy and prognosis of adenocarcinoma of lung.
机构地区 日照市人民医院
出处 《山东医药》 CAS 北大核心 2007年第22期22-23,共2页 Shandong Medical Journal
关键词 肺肿瘤 P27蛋白 分化程度 预后 lung neoplasms p27 protein cell differentiation prognosis
  • 相关文献

参考文献5

  • 1Loda M,Cukor B,Tam SW,et al.Increased proteasome-dependant degradation of cyclin-dependant kinase inhibitor P27 in aggressive coloreactal carcinomas[J].Nat Med,1997,3(5):231-234.
  • 2Ciaparrone M,Yamamoto H,Yao Y,et al.Localization and experssion of p27kipl multistage colorectal carcinogenesis[J].Cancer Res,1998,58(1):114-122.
  • 3Catzavelos C,Tsao MS,De Boer G,et al.Reduced espression of the cell cycle inhibitor p27kipl in non-small cell lung carcinomas:a prognostic factor independent of Ras[J].Cancer Res,1999,59(3):684-688.
  • 4Takahashi S,Kamata Y,Tamo W,et al.Relationship between postoperative recurrence and expression of cyclin E,p27,and Ki-67 in non-small cell lung cancer without lymph node metastases[J].Int J Clin Oncol,2002,7(6):349-355.
  • 5Lara PN,Davies AM,Mack PC,et al.Proteasome inhibition with PS-341(bortesomib)in lung cancer therapy[J].Semin Oncol,2004,31(suppl 1):40-46.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部